FONR
FONAR CorporationNASDAQHealthcare$18.59+0.05%ClosedMarket Cap: $114.8M
As of 2026-04-06
Valuation
P/E (TTM)
15.19
PEG
—
P/B
0.66
P/S
1.08
EV/EBITDA
6.21
DCF Value
$25.38
FCF Yield
5.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
40.8%
Operating Margin
10.1%
Net Margin
7.1%
ROE
4.3%
ROA
3.5%
ROIC
4.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 2026 | $25.5M | 37.9% | $3.0M | $2.1M | $0.31 | — |
| Q1 2026 | $26.0M | 40.1% | $3.2M | $2.3M | $0.34 | — |
| Q4 2025 | $27.3M | 40.4% | $894.8K | $729.3K | $0.11 | — |
| FY 2025 | $104.4M | 81.7% | $11.6M | $8.3M | $1.23 | — |
| Q3 2025 | $27.2M | 44.5% | $3.7M | $2.5M | $0.38 | — |
| Q2 2025 | $24.9M | 39.0% | $2.4M | $2.0M | $0.29 | — |
| Q1 2025 | $25.0M | 40.2% | $4.6M | $3.1M | $0.46 | — |
| Q4 2024 | $25.9M | 40.8% | $1.3M | $830.4K | $0.11 | — |
| FY 2024 | $102.9M | 43.9% | $16.5M | $10.6M | $1.53 | — |
| Q3 2024 | $25.7M | 45.7% | $3.7M | $1.9M | $0.28 | — |
| Q2 2024 | $25.4M | 42.9% | $4.9M | $3.8M | $0.54 | — |
| Q1 2024 | $25.8M | 46.1% | $6.6M | $4.1M | $0.59 | — |